In Brief This Week: PerkinElmer; Hologic; Accelerate Diagnostics; ATCC | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer laid off 22 employees during the second quarter as a result of a restructuring plan to focus resources on higher growth end markets, the company said in its Form 10-Q filed with the US Securities and Exchange Commission this week. In total PerkinElmer took a pre-tax restructuring charge of $800,000 in its Human Health and Environmental Health segments related to the workforce reductions during Q2.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.